NCT00237991View on ClinicalTrials.gov

Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

June 30, 2005

Conditions
Hepatitis A
Interventions
BIOLOGICAL

Hepatitis A

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00237991 - Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population | Biotech Hunter | Biotech Hunter